What MeiraGTx Holdings PLC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 3 | 10 |
| Total trades | 3 | 45 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 45 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Giroux Richard | CFO & COO | Oct 20 | Disclosed 10b5-1 sale · S | −56,000 | $9.95 | −$557K | 852,530 |
| Naylor Stuart | CHIEF SCI OFCR, OPHTHALMOLOGY | Oct 06 | Disclosed 10b5-1 sale · S | −27,659 | $10.64 | −$294K | 613,187 |
| Forbes Alexandria | PRESIDENT & CEO | Aug 18 | Disclosed 10b5-1 sale · S | −62,000 | $13.86 | −$859K | 1,325,695 |
| Giroux Richard | CFO & COO | Jul 21 | Disclosed 10b5-1 sale · S | −56,000 | $12.51 | −$701K | 908,530 |
| Naylor Stuart | CHIEF SCI OFCR, OPHTHALMOLOGY | Jul 07 | Disclosed 10b5-1 sale · S | −25,112 | $14.90 | −$374K | 640,846 |
| Naylor Stuart | CHIEF SCI OFCR, OPHTHALMOLOGY | Jul 07 | Disclosed 10b5-1 sale · S | −2,547 | $13.86 | −$35.3K | 665,958 |
| Harris Keith R. | Director | Jun 10 | Exercise / conversion · M | +75,000 | — | — | 200,000 |
| Giroux Richard | CFO & COO | May 27 | Gift · G | −7,000 | — | — | 964,530 |
| Forbes Alexandria | PRESIDENT & CEO | May 19 | Disclosed 10b5-1 sale · S | −62,000 | $9.17 | −$569K | 1,387,695 |
| Giroux Richard | CFO & COO | Apr 21 | Disclosed 10b5-1 sale · S | −56,000 | $10.22 | −$572K | 971,530 |
| Perceptive Advisors Llc | Director | Apr 17 | Grant / award · A | +555,555 | $9.00 | +$5M | 10,786,658 |
| Naylor Stuart | CHIEF DEV. OFFICER | Apr 07 | Disclosed 10b5-1 sale · S | −27,661 | $9.36 | −$259K | 668,505 |
| Forbes Alexandria | PRESIDENT & CEO | Mar 24 | Disclosed 10b5-1 sale · S | −62,000 | $7.41 | −$459K | 1,449,695 |
| Giroux Richard | CFO & COO | Feb 21 | Withheld — tax / exercise cost · F | −31,726 | $7.45 | −$236K | 1,027,530 |
| Giroux Richard | CFO & COO | Feb 21 | Exercise / conversion · M | +60,000 | — | — | 1,059,256 |
| Forbes Alexandria | PRESIDENT & CEO | Feb 21 | Withheld — tax / exercise cost · F | −33,048 | $7.45 | −$246K | 1,511,695 |
| Forbes Alexandria | PRESIDENT & CEO | Feb 21 | Exercise / conversion · M | +62,500 | — | — | 1,544,743 |
| Naylor Stuart | CHIEF DEV. OFFICER | Feb 21 | Withheld — tax / exercise cost · F | −11,750 | $7.45 | −$87.5K | 696,166 |
| Naylor Stuart | CHIEF DEV. OFFICER | Feb 21 | Exercise / conversion · M | +25,000 | — | — | 707,916 |
| Wollin Robert J | GENERAL COUNSEL AND SECRETARY | Feb 21 | Withheld — tax / exercise cost · F | −5,949 | $7.45 | −$44.3K | 57,377 |
Loading...
